Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab

Ann Rheum Dis. 2006 Jun;65(6):834-5. doi: 10.1136/ard.2005.044453.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Adalimumab
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Fatal Outcome
  • Female
  • Humans
  • Lung / diagnostic imaging
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / complications*
  • Pulmonary Fibrosis / diagnostic imaging
  • Scleroderma, Systemic / complications*
  • Scleroderma, Systemic / diagnostic imaging
  • Scleroderma, Systemic / drug therapy
  • Tomography, X-Ray Computed
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab